Related Experiment Videos
A palm-worn device to quantify rigidity in Parkinson's disease.
Thushara Perera1, Wee-Lih Lee2, Mary Jones3
1Bionics Institute, East Melbourne, Victoria, Australia; Department of Medical Bionics, University of Melbourne, East Melbourne, Victoria, Australia.
Journal of Neuroscience Methods
|February 19, 2019
Summary
A new palm-worn device objectively measures Parkinsonian rigidity, showing moderate agreement with clinical scales and sensitivity to deep brain stimulation (DBS) effects. This tool offers continuous monitoring for Parkinson's disease management.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Medical Devices
Background:
- Parkinsonian rigidity, a key motor symptom, is clinically assessed via subjective ordinal scales like the MDS-UPDRS.
- Objective, instrumented measurement of rigidity could offer greater mechanistic understanding and precision.
Purpose of the Study:
- To introduce and validate a novel palm-worn instrument for objective, continuous quantification of Parkinsonian rigidity.
- To assess the instrument's congruence with the MDS-UPDRS, its sensitivity to deep brain stimulation (DBS) and contralateral limb movement, and its performance compared to healthy individuals.
Main Methods:
- A palm-worn device was developed using a miniature motor to flex the third digit and transducers to measure forces.
- Eight participants with Parkinson's disease were evaluated on and off DBS, with and without contralateral limb activation.
- Wash-in/out effects of DBS were tracked, alongside comparisons with two blinded clinical raters and 16 healthy volunteers.
Main Results:
- The instrument demonstrated moderate agreement with the MDS-UPDRS ratings.
- Significant differences in rigidity were observed based on therapeutic state (DBS on/off), activation conditions, and disease versus healthy cohorts.
- Rigidity increased after DBS cessation and improved upon DBS resumption, with gradual changes tracked over time.
Conclusions:
- The developed instrument provides an objective, continuous measure of Parkinsonian rigidity.
- The device shows sensitivity to therapeutic interventions like DBS and contralateral movement, offering potential advantages over existing methods.
- This technology could be valuable for continuous monitoring in clinical settings or where expert raters are unavailable.